FDA Approves BSX Renal Stent

Boston Scientific (NYSE:BSX), the Natick, MA-based medical devices giant, says that the FDA has approved its stent for certain patients who undergo surgeries to remove plaques from their renal arteries. The stent is designed to prop open renal arteries, which are the main source of blood to the kidneys.

Trending on Xconomy